Claims for Patent: 7,723,313

✉ Email this page to a colleague

Summary for Patent: 7,723,313

Title:	Methods and compositions for inhibiting angiogenesis
Abstract:	The present invention provides a method of inhibiting angiogenesis within a tissue by providing exogenous PEDF to cells associated with the tissue. The presence of exogenous PEDF inhibits angiogenesis within the tissue, in part by interfering with the ability of vascular endothelia to expand within the tissue. The invention also provides a method for determining the severity of a tumor be assaying for the presence of PEDF within the tumor. To facilitate the inventive methods, the present invention provides pharmaceutical compositions including sources of PEDF.
Inventor(s):	Noel P. Bouck, David W. Dawson, Paul R. Gillis, Olga Volpert, Susan E. Crawford, Veronica M. Stellmach
Assignee:	Northwestern University
Application Number:	US11/494,363

Details for Patent 7,723,313

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Mannkind Corporation	AFREZZA	insulin human	Powder	022472	June 27, 2014	7,723,313	2026-07-26
Mannkind Corporation	AFREZZA	insulin human	Powder	022472	April 17, 2015	7,723,313	2026-07-26
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 7,723,313

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Austria	E413185	⤷ Start Trial
Australia	3985501	⤷ Start Trial
Australia	741886	⤷ Start Trial
Australia	8509098	⤷ Start Trial
Canada	2298018	⤷ Start Trial
Canada	2401096	⤷ Start Trial
Canada	2410699	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.